Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Contineum Therapeutics (CTNM) FCF Margin (2023)

Contineum Therapeutics has reported FCF Margin over the past 1 years, most recently at 81.29% for Q2 2023.

  • Quarterly results put FCF Margin at 81.29% for Q2 2023, changed N/A from a year ago — trailing twelve months through Mar 2024 was 32.22% (changed N/A YoY), and the annual figure for FY2023 was 37.87%, changed.
  • FCF Margin for Q2 2023 was 81.29% at Contineum Therapeutics, down from 5756.52% in the prior quarter.
  • Over the last five years, FCF Margin for CTNM hit a ceiling of 5756.52% in Q1 2023 and a floor of 81.29% in Q2 2023.